PharVision Advisers’s monday.com MNDY Stock Holding History

PharVision Advisers’s Portfolio MNDY Stock Details MNDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,871	Closed	-$424K	–	435
2025 Q4	$424K	Buy	+2,871	New	+$484K	0.21%	98

Other funds holding MNDY

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Sonnipe Ltd Douglas, Isle Of Man $137M AUM 71.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RGC

Rubicon Global Capital London, United Kingdom $235M AUM 40.47% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PharVision Advisers's MNDY Position: Q1 2026 in Review

PharVision Advisers sold out of monday.com (MNDY) in Q1 2026, closing a stake of 2,871 shares — an estimated $424K sold.

PharVision Advisers first reported a position in MNDY in Q4 2025 and held it in 1 quarter. The position peaked at $424K in Q4 2025. 304 funds tracked by Wall St. Rank hold MNDY as of Q1 2026.

PharVision Advisers reported no remaining monday.com position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 2,871 monday.com shares in Q1 2026, an estimated $424K.
PharVision Advisers first reported a position in monday.com in Q4 2025 and held it in 1 quarter.
PharVision Advisers's monday.com position peaked at $424K in Q4 2025.
304 funds tracked by Wall St. Rank held monday.com as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.